HARROW, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21.6 USD | +3.62% |
|
+2.88% | +92.90% |
| 06-24 | Harrow, Inc.(NasdaqGM:HROW) added to S&P Pharmaceuticals Select Industry Index | CI |
| 06-21 | Craig-Hallum Adjusts Price Target on Harrow Health to $30 From $26, Buy Rating Maintained | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| HARROW, INC. | Other Pharmaceuticals | +3.62% | +2.88% | +92.90% | +17.71% | +178.41% | 764M |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- HROW Stock
- Charts Harrow, Inc.
- Comparison Chart
